Therapeutic Asset Ratings

Peau d'Orange

Peritoneal High Grade Serous Adenocarcinoma

Phase 2

Recurrent High Grade Ovarian Serous Adenocarcinoma

Stage 1 cT1b-T1cN0M0

Unresectable Adrenal Gland Pheochromocytoma

Vascular Neoplasm

Inflammatory Breast Carcinoma

Renal Cell Carcinoma

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Post-transplant MRD-guided Maintenance Therapy

Acute Myeloid Leukemia With BCR-ABL1

Post-transplant MRD-guided Maintenance Therapy

Acute Myeloid Leukemia, Inv(16)(P13.1;Q22)

Acute Myeloid Leukemia, T(16;16)(P13.1;Q22)

Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Dedifferentiated Chondrosarcoma

Bone Giant Cell Tumor

Malignancy In Giant Cell Tumor Of Bone

Ovarian Carcinosarcoma

Poorly Differentiated Thyroid Gland Carcinoma

Post-transplant MRD-guided Maintenance Therapy

Thyroid Gland Undifferentiated (Anaplastic) Carcinoma

Thyroid Gland Squamous Cell Carcinoma